Status:
COMPLETED
PRIMARA: A Prospective Descriptive Observational Study to Review Mimpara (Cinacalcet) Use in Patients With Primary Hyperparathyroidism in Clinical Practice
Lead Sponsor:
Amgen
Conditions:
Hyperparathyroidism, Primary
Eligibility:
All Genders
18+ years
Brief Summary
This is a multicentre, descriptive observational study of adult patients with primary HPT receiving cinacalcet in clinical practice in a number of countries in Europe. Patients will be enrolled within...
Eligibility Criteria
Inclusion
- at least 18 years of age at the time of first administration of cinacalcet
- patients with primary HPT who have initiated cinacalcet within 1 month before enrolment in the study
- provision of informed consent (if required)
Exclusion
- previous use of cinacalcet (other than within 1 month before enrolment)
- diagnosed secondary HPT
- other known aetiology of hypercalcaemia (eg, sarcoidosis, tuberculosis)
Key Trial Info
Start Date :
October 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
305 Patients enrolled
Trial Details
Trial ID
NCT00928408
Start Date
October 1 2009
End Date
February 1 2012
Last Update
August 1 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.